Ilyda SA
Ilyda SA engages in software development business in Greece. It offers enterprise resource planning systems, such as MegaTron ERP and Kinitron Smart ERP; Dioscourides Smart, Dioscourides Touch XPress, and Dioscourides ERP Retail System for pharmacies; MegaTron Pharma ERP for drugstores; and LIS Bio-Diagnosis for microbiological laboratories. The company also provides MegaTron DEVA for water suppl… Read more
Ilyda SA (ILYDA) - Total Liabilities
Latest total liabilities as of December 2022: €1.78 Million EUR
Based on the latest financial reports, Ilyda SA (ILYDA) has total liabilities worth €1.78 Million EUR as of December 2022.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Ilyda SA - Total Liabilities Trend (2015–2022)
This chart illustrates how Ilyda SA's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Ilyda SA Competitors by Total Liabilities
The table below lists competitors of Ilyda SA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Kingsmen C.M.T.I. Public Company Limited
BK:K
|
Thailand | ฿367.99 Million |
|
Questor Technology Inc
PINK:QUTIF
|
USA | $2.77 Million |
|
INTUITIVE SURGICAL (IUI1.SG)
STU:IUI1
|
Germany | €2.07 Billion |
|
Constellation Resources Ltd
AU:CR1
|
Australia | AU$494.25K |
|
New England Realty Associates LP
NYSE MKT:NEN
|
USA | $563.89 Million |
|
IVF_INSPIRE IVF
BK:IVF
|
Thailand | ฿84.37 Million |
|
NEP Realty and Industry Public Company Limited
BK:NEP
|
Thailand | ฿6.62 Million |
|
Pharma-Bio Serv Inc
OTCQB:PBSV
|
USA | $1.74 Million |
Liability Composition Analysis (2015–2022)
This chart breaks down Ilyda SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.95 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 2.67 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.27 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.21 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Ilyda SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Ilyda SA (2015–2022)
The table below shows the annual total liabilities of Ilyda SA from 2015 to 2022.
| Year | Total Liabilities | Change |
|---|---|---|
| 2022-12-31 | €1.78 Million | -50.67% |
| 2021-12-31 | €3.60 Million | -20.83% |
| 2019-12-31 | €4.55 Million | +10.21% |
| 2018-12-31 | €4.13 Million | -20.83% |
| 2017-12-31 | €5.21 Million | +0.20% |
| 2016-12-31 | €5.20 Million | -16.33% |
| 2015-12-31 | €6.22 Million | -- |